A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa | MicrobiomeTrials← Back to trialsNCT07727889
A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2027-07-01
Enrollment target: 50 participants Locations- No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Hidradenitis Suppurativa
The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) f…
Miami, United StatesCompleted Jul 21, 2026
Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), ingu…
Birmingham, United StatesEst. completion Mar 2028